PubRank

P A SHORE

Author PubWeight™ 76.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959 16.61
2 The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther 1957 3.99
3 Serotonin release as a possible mechanism of reserpine action. Science 1955 3.03
4 Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J Biol Chem 1954 2.78
5 A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci 1957 2.71
6 Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther 1958 2.37
7 Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther 1956 2.26
8 Evidence that serotonin has a role in brain function. Science 1955 2.13
9 Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science 1955 1.99
10 Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther 1957 1.86
11 Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. J Pharmacol Exp Ther 1959 1.63
12 BINDING AND RELEASE OF METARAMINOL: MECHANISM OF NOREPINEPHRINE DEPLETION BY ALPHA-METHYL-M-TYROSINE AND RELATED AGENTS. J Pharmacol Exp Ther 1964 1.56
13 Possible interrelationship between release of brain norepinephrine and serotonin by reserpine. Science 1957 1.54
14 Release of serotonin and catecholamines by drugs. Pharmacol Rev 1962 1.53
15 Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835). J Pharmacol Exp Ther 1960 1.41
16 Role of brain serotonin in reserpine action. Ann N Y Acad Sci 1957 1.40
17 Release of serotonin from blood platelets by reserpine in vitro. J Pharmacol Exp Ther 1957 1.39
18 Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain. J Neurochem 1961 1.35
19 RELEASE OF METARAMINOL (ARAMINE) FROM THE HEART BY SYMPATHETIC NERVE STIMULATION. Science 1964 1.33
20 MECHANISM OF ACTION OF RESERPINE AND INSULIN ON GASTRIC AMINES AND GASTRIC ACID SECRETION, AND THE EFFECT OF MONOAMINE OXIDASE INHIBITION. J Pharmacol Exp Ther 1963 1.28
21 Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. Ann N Y Acad Sci 1959 1.17
22 Interaction of drugs with norepinephrine in the brain. Pharmacol Rev 1959 1.15
23 Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system. Experientia 1955 1.14
24 Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase. Biochem Pharmacol 1960 1.14
25 On the mechanism of action of reserpine: effect of reserpine on capacity of tissues to bind serotonin. J Pharmacol Exp Ther 1957 1.13
26 Serotonin storage mechanism and its interaction with reserpine. Experientia 1958 1.04
27 FLUOROMETRIC ESTIMATION OF METARAMINOL AND RELATED COMPOUNDS. Life Sci 1964 1.01
28 Serotonin changes in platelets and brain induced by small daily doses of reserpine; lack of effect of depletion of platelet serotonin on hemostatic mechanisms. N Engl J Med 1957 0.98
29 A simple technique involving solvent extraction for the estimation of norepinephrine and epinephrine in tissues. Pharmacol Rev 1959 0.97
30 Distribution of norepinephrine in the heart. Nature 1958 0.97
31 Potentiating action of chlorpromazine and reserpine. Nature 1955 0.95
32 Release of blood platelet serotonin by reserpine and lack of effect on bleeding time. J Pharmacol Exp Ther 1956 0.95
33 Persistence of reserpine action after the disappearance of drug from brain: effect on serotonin. J Pharmacol Exp Ther 1956 0.92
34 Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action. Science 1956 0.89
35 Anticonvulsant properties of monoamine oxidase inhibitors. Ann N Y Acad Sci 1959 0.89
36 On the physiologic significance of monoamine oxidase in brain. Science 1957 0.87
37 LSD-like effects elicited by reserpine in rabbits pretreated with iproniazid. Proc Soc Exp Biol Med 1957 0.83
38 PLATELET DAMAGE INDUCED IN PLASMA BY CERTAIN FATTY ACIDS. Nature 1963 0.81
39 Effect of reserpine, serotonin, and 5-hydroxytryptophan on rabbit platelet histamine in vivo and in vitro. Biochem Pharmacol 1960 0.81
40 A microfluorometric method for the determination of agmatine. Anal Biochem 1961 0.81
41 Sex difference in histamine metabolism in the rat. Am J Physiol 1961 0.80
42 INTRACELLULAR DISTRIBUTION OF METARAMINOL AND RELATED COMPOUNDS IN RAT HEART. Life Sci 1965 0.79
43 An interpretation of the action of psychotropic drugs. Postgrad Med 1958 0.77
44 Observations on the fate of dromoran in the dog and its secretion into the gastric juice. J Pharmacol Exp Ther 1955 0.77
45 On the reported inhibition of monoamine oxidase by an agent with sedative properties. Science 1960 0.77
46 FLUOROMETRIC MEASUREMENT OF HISTAMINE. Methods Med Res 1964 0.75
47 An anticonvulsant effect of monoamine oxidase inhibitors. Experientia 1959 0.75
48 Effect of iproniazid on brain levels of norepinephrine and serotonin. Science 1958 0.75
49 Release of rabbit platelet histamine by serum in vitro. Am J Physiol 1962 0.75
50 THE EFFECT OF DESMETHYLIMIPRAMINE ON RESERPINE AND INSULIN-INDUCED RELEASE OF GASTRIC HISTAMINE AND ADRENAL CATECHOLAMINES. Life Sci 1964 0.75
51 [Histamine metabolism in male and female rats]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1961 0.75
52 Possible mechanism of antidepressant action of marsilid. J Clin Exp Psychopathol 1958 0.75
53 PARALLEL INHIBITION OF SPONTANEOUS AND ANTIGEN-INDUCED PLATELET HISTAMINE RELEASE. Am J Physiol 1963 0.75
54 Recent biochemical developments with monoamine oxidase inhibitors. Dis Nerv Syst 1960 0.75
55 Biochemical, physiological, and pharmacological aspects of serotonin. Recent Prog Horm Res 1957 0.75